DRUG STUDY
GENERIC NAME: TRAMADOL Route of Administration: DRUG CLASS
Therape utic Class: analgesic s (centrally acting)
MODE OF ACTION Chemical Effect: Binds to mu-opiod receptors. Inhibits reuptake of serotonin and norepineph rine in the CNS. Therapeut ic effect: Decreased pain
INIDCATIONS/ CONTRA INDICATIONS
Dosage : 50 mg ADVERSE REACTIONS TO WATCH FOR
I: moderate Sedation, to moderately dizziness/vertigo, severe pain headache, confusion, C/I: pregnancy; allergy to tramadol; acute intoxication with alcohol, opioi ds, psychotropic drugs or other centrally acting analgesics; lactation. Use cautiously with seizures, concomitant
dreaming, anxiety, seizures, Hypotension, Hypotension, tachycardia, bradycardia , Sweating,pruritus, Sweating,pruritus, rash, pallor, urticaria, Nausea, vomiting, dry mouth, constipation, flatulence Potential for abuse, anaphylactoid r eactions
BRAND NAME: Available Stock:
DRUG INTERACTIONS
NURSING NURSING CONSIDERATIONS
Decreased effectiveness with carbamazepi ne
Assess bowel function routinely. Minimize constipation.
Increased risk Assess previous of tramadol to analgesic history. Tramadol Tramadol is not not xicity recommended with MAOIs for opiod dependent patients (withdrawal symptoms) Monitor patients for seizures. May cause ↑ serum creatinine, elevated liver enzymes, decreased hemoglobin and
HEALTH TEACHINGS
Instruct the patient on how and when to ask for pain medication. Caution to avoid activities requiring alertness until response to medication is unknown. Caution to avoid alcohol or other CNS depressants Encourage patient to
use of CNS depressants or MAOIs, renal or hepatic impairment.
proteinuria. Overdose/ toxicity may cause respiratory depression. Naloxone (Narcan) may reverse it.
turn, cough, breathe deeply every 2 hr to prevent atelectasis.
